Dompe Pharmaceuticals   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Milan Italy (1866)

Organization Overview

First Clinical Trial
2005
NCT00224406
First Marketed Drug
2018
cenegermin-bkbj (oxervate)
First NDA Approval
2018
cenegermin-bkbj (oxervate)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

DOMPE FARMACEUTICI | Dompé Farmaceutici | Dompé Farmaceutici S.p.A | Dompé s.p.a., Milan | Dompé SpA Milan | Dompé US | Domp Farmaceutici SpA